Literature DB >> 25446151

Sex-dependent pathophysiological mechanisms in hypertrophic cardiomyopathy: implications for rhythm disorders.

Louise L A M Nijenkamp1, Ahmet Güçlü2, Yolande Appelman3, Jolanda van der Velden4, Diederik W D Kuster5.   

Abstract

Differences in cardiac physiology are seen between men and women in terms of health and disease. Sex differences start to develop at puberty and are maintained during aging. The prevalence of almost all cardiovascular diseases is found to be higher in men than in women, and disease progression tends to be more rapid in male than in female patients. In cohorts of patients with hypertrophic cardiomyopathy (HCM), the most common autosomal inherited cardiac disease, men are overrepresented, suggesting increased penetrance of HCM-causing mutations in male patients. Cardiac remodeling in patients with HCM is higher in men than in women, the same is seen in HCM animal models. Patients with HCM are at increased risk of sudden cardiac death (SCD) and developing rhythm disorders. There seems to be no sex effect on the risk of SCD or arrhythmias in patients with HCM; however, animal studies suggest that certain mutations predispose men to SCD.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmias; Atrial fibrillation; Hypertrophic cardiomyopathy; Pathophysiology; Sex; Sudden cardiac death

Mesh:

Year:  2014        PMID: 25446151     DOI: 10.1016/j.hrthm.2014.10.032

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  3 in total

1.  Association between functional mitral regurgitation and recurrence of paroxysmal atrial fibrillation following catheter ablation: a prospective cohort study.

Authors:  Fusheng Ke; Yinhui Huang; Zhexiu Jin; Lei Huang; Qiang Xiong; Fang Jia; Yu Chen; Gang Chen
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

Review 2.  Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy.

Authors:  Gherardo Finocchiaro; Emma Magavern; Gianfranco Sinagra; Euan Ashley; Michael Papadakis; Maite Tome-Esteban; Sanjay Sharma; Iacopo Olivotto
Journal:  J Am Heart Assoc       Date:  2017-12-13       Impact factor: 5.501

Review 3.  Clinical presentations of hypertrophic cardiomyopathy and implications for therapy.

Authors:  Carles Díez-López; Joel Salazar-Mendiguchía
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.